Navigation Links
Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
Date:3/12/2008

DETROIT MI Researchers at Henry Ford Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new option for those suffering with advanced emphysema. The study focuses on a new procedure, called airway bypass, that involves creating pathways in the lung for trapped air (one of the primary causes of shortness breath) to escape.

Henry Ford is the only hospital in Detroit participating in the study.

Chronic obstructive pulmonary disease (COPD) is a term referring to two lung diseases, chronic bronchitis and emphysema, that are characterized by obstruction to airflow that interferes with normal breathing. COPD is the fourth leading cause of death in the United States and is projected to be the third leading cause of death for men and women by the year 2020. There is no cure for COPD.

Emphysema is an irreversible disease characterized by the destruction of lung tissue and a subsequent decrease of the lungs natural elasticity, which causes the small airways of the lungs to collapse. Shortness of breath worsens as this process progresses, eventually leading to a situation where all of the inhaled air cannot be exhaled, and in essence air becomes trapped in the chest. This hyperinflation significantly contributes to the shortness of breath experienced by patients with emphysema.

We are excited to be part of this study because currently there are limited treatment options for most patients with emphysema beyond lung transplantation. Patients usually have very poor quality of life, as each breath can be difficult, says Michael Simoff, M.D., a Henry Ford pulmonologist and principal investigator of the study.

By creating new pathways for airflow with the airway bypass procedure, we hope to reduce hyperinflation and all the problems it causes for patients. If pati
'/>"/>

Contact: Meghan Oreste
moreste@comcast.net
617-823-1441
Broncus Technologies
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Grosse Pointes Cottage Hospital Joins Henry Ford Health System
2. CNS Response, Inc. Names Henry T. Harbin, MD to Board of Directors
3. Fund-Raiser for Henry Ford Hospitals Stroke Program
4. Program for Stroke Survivors and Friends Hosted by Henry Ford Hospital
5. Repligen Elects Earl Henry, M.D. to the Board of Directors
6. Michigan Quality Council (MQC) Names Henry Ford Health System 2007 State Quality Award Recipient
7. AAPD to Present 2008 Henry B. Betts Award to International Human Rights Disability Advocate Eric Rosenthal
8. Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein Medical Systems MicroMD(R) EMR 5.0
9. Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
10. New research explores newborn in-hospital weight loss
11. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
(Date:11/9/2009)...v. 9 Sutter Health, a family of do...are service providers, is donating $255,000 to foo...ocal food banks will share the quarter-million-dol...tables of thousands of families across the north s...partnering with and supporting charitable programs...
(Date:11/9/2009)...s with drugs that inhibit estrogen, , ,... to treat breast cancer and osteoporosis eliminate...y. , The drugs also cleared precancerous growth...t of cancer in mice with precancerous lesions. ,...t cancer/osteoporosis drug raloxifene were given t...
(Date:11/9/2009)... both eye conditions are age-related, researchers ...-- Cataract surgery doesn,t appear to speed the pr...), according to a new study that challenges the be...s the other. , "Because both conditions are str...also have AMD," wrote Li Ming Dong, of Stony Brook...
(Date:11/9/2009)...9 /PRNewswire-FirstCall/ - Hard To Treat Diseases ...hat Novartis, a US$41 billion international health...1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmac... Switzerland will begin a five-year, $1 billion Ch...matically increase its investment in its China R&a...
(Date:11/9/2009)...sive Cancer Network (NCCN) has posted a draft whit...radigm for near-term comparative effectiveness cli...cument introduces the NCCN Comparative Therapeutic...ompares the risk-versus-benefit of different treat...tice Guidelines in Oncology(TM). The paper will be...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4
...hiladelphia, PA, June 25, 2007 State policies hav...y substance abuse treatment programs, and could pl...arch-based "comprehensive" treatment approaches, r...licy proscriptions emanating from scientific resea...
...tem cell research and the potential use of human e...oversial issue which splits both scientific and pu...stem cells throughout the world deals particularly...t. It is a symbolic struggle over the whole future...
...y dose of rivaroxaban cut risk of venous thromboem... (HealthDay News) -- Extended use of the oral drug... clots after hip replacement surgery, British res.... Current guidelines recommend patients receive a ...
...ARBOR, Mich., June 25 HealthMedia(R), Inc.,s,Succ...o-year Health,Information Products (HIP) Certifica...ance (NCQA), the most trusted source for informati...A, since responsibility for adherence to NCQA HRA ...
...cal Division Officer says " ... when we used Jelly...patients from the painful burning and stinging ...act.", SAVANNAH, Ga., June 25 Captain Kevin Carv...at provided,any true relief until he tried Jellyfi...
...R KNOLLS, N.J., June 25 MedeFile,International, I...zing in,portable electronic medical records manage...usive, membership only, resort community located i...ting of over 1,400 members., Members who subscrib...
Other Medicine News:Health News:State policies influence drug treatment programs 2Health News:Stem cell research from an ethical point of view 2Health News:Oral Drug Helps Prevent Clotting After Hip Replacement 2Health News:HealthMedia Health Risk Assessment Earns Prestigious NCQA Certification 2Health News:Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 2Health News:Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 3Health News:Exclusive Resort Community Looks to MedeFile to Provide Members With Access to Medical Records Anytime, Anywhere 2
(Date:11/9/2009)...RMINGHAM, Ala., Nov. 9 S...at it will host an investor conference call at 11:... to discuss its 2009 third quarter operating resul...ly an hour following the conclusion of the confere...gi-bin/prnh/20080812/CLTU111LOGO ) ,, Please...
(Date:11/9/2009)...DFORD, Mass., Nov. 9 Hol... ), a leading developer, manufacturer and supplier...nd surgical products dedicated to serving the heal... for the fourth quarter and fiscal year ended Sept...ed the Board of Directors has promoted Robert Casc...
(Date:11/9/2009)...ENWOOD, Ill., Nov. 9 La...n personal and environmental radiation monitoring ...quisitions in accordance with its long-term strate...the acquisitions of Global Physics Solutions, Inc....ll Saxelby, President and CEO of Landauer. "These ...
Breaking Medicine Technology:Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 28Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 50494 1Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 50494 2Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 50494 3Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community 50494 4Human Genome Sciences to Host July 20 Conference Call to Discuss Top Line Phase 3 Results for Benlysta 28TM 29 28Formerly Lymphostat B 28R 29 29 in S 12863 1Human Genome Sciences to Host July 20 Conference Call to Discuss Top Line Phase 3 Results for Benlysta 28TM 29 28Formerly Lymphostat B 28R 29 29 in S 12863 2Siemens Hearing Instruments Introduces Affordable and Flexible Pure 300 50492 1Siemens Hearing Instruments Introduces Affordable and Flexible Pure 300 50492 2
Vitreoretinal Viscodissector 45 degrees
Infusion Cannula 6mm
Lacrimal Intubation Tubing
Replacment Tubing
Medicine Products: